- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 207/18 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
Patent holdings for IPC class C07D 207/18
Total number of patents in this class: 50
10-year publication summary
|
6
|
4
|
1
|
3
|
2
|
0
|
2
|
3
|
1
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Pfizer Inc. | 3387 |
4 |
| Dow Global Technologies LLC | 10363 |
2 |
| Asahi Glass Company, Limited | 2786 |
2 |
| Alere San Diego, Inc. | 63 |
2 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2157 |
2 |
| Nissan Chemical Industries, Ltd. | 1717 |
2 |
| The UAB Research Foundation | 643 |
2 |
| Theravance Biopharma R&D IP, LLC | 458 |
2 |
| ReNAgade Therapeutics Management Inc. | 45 |
2 |
| Bristol-myers Squibb Company | 4898 |
1 |
| The Regents of the University of California | 19918 |
1 |
| Allergan, Inc. | 2349 |
1 |
| Bayer Intellectual Property GmbH | 2499 |
1 |
| Sumitomo Chemical Company, Limited | 9046 |
1 |
| The Johns Hopkins University | 5667 |
1 |
| Apeiron Catalysts Sp. zo.o | 1 |
1 |
| Asymchem Life Science (Tianjin) Co., Ltd | 88 |
1 |
| Biogen Inc. | 18 |
1 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 702 |
1 |
| Cornell University | 3306 |
1 |
| Other owners | 19 |